7-107695949-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2PM5PP3_ModeratePP5
The NM_000441.2(SLC26A4):c.1454C>T(p.Thr485Met) variant causes a missense change. The variant allele was found at a frequency of 0.0000481 in 1,599,856 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T485R) has been classified as Pathogenic.
Frequency
Consequence
NM_000441.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC26A4 | NM_000441.2 | c.1454C>T | p.Thr485Met | missense_variant | 13/21 | ENST00000644269.2 | NP_000432.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC26A4 | ENST00000644269.2 | c.1454C>T | p.Thr485Met | missense_variant | 13/21 | NM_000441.2 | ENSP00000494017 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000461 AC: 7AN: 151878Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000278 AC: 7AN: 251402Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135868
GnomAD4 exome AF: 0.0000483 AC: 70AN: 1447978Hom.: 0 Cov.: 28 AF XY: 0.0000471 AC XY: 34AN XY: 721470
GnomAD4 genome AF: 0.0000461 AC: 7AN: 151878Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74146
ClinVar
Submissions by phenotype
Pendred syndrome Pathogenic:2Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Myriad Genetics, Inc. | Nov 03, 2021 | NM_000441.1(SLC26A4):c.1454C>T(T485M) is a missense variant classified as a variant of uncertain significance in the context of Pendred syndrome. T485M has been observed in cases with relevant disease (PMID: 21366435, 21704276). Functional assessments of this variant are not available in the literature. T485M has been observed in population frequency databases (gnomAD: EAS 0.01%). In summary, there is insufficient evidence to classify NM_000441.1(SLC26A4):c.1454C>T(T485M) as pathogenic or benign. Please note: this variant was assessed in the context of healthy population screening. - |
Pathogenic, no assertion criteria provided | clinical testing | The Core Laboratory in Medical Center of Clinical Research, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine | May 12, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Mendelics | May 04, 2022 | - - |
not provided Pathogenic:1Uncertain:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 26, 2023 | This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 485 of the SLC26A4 protein (p.Thr485Met). This variant is present in population databases (rs370029782, gnomAD 0.01%). This missense change has been observed in individual(s) with SLC26A4-related conditions (PMID: 21366435, 21704276, 34545167). ClinVar contains an entry for this variant (Variation ID: 554960). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC26A4 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects SLC26A4 function (PMID: 34545167). This variant disrupts the p.Thr485 amino acid residue in SLC26A4. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 18285825, 19017801). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Feb 01, 2023 | Published functional studies suggest a damaging effect due to reduced transport of iodide compared to wild-type (Zhang et al., 2022); Observed in homozygous state in patients with hearing loss referred for genetic testing at GeneDx and in the literature (Mercer et al., 2011), and also observed in homozygous state in multiple unrelated healthy adult individuals tested at GeneDx; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27771369, 34545167, 21704276, 21366435) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at